Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone

Journal of the American Academy of Dermatology

Volumn 58, Issue 1, 2008, Pages 60-62

  Krunic, Aleksandar ^a   Ciurea, Ana ^a   Scheman, Andrew ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT; POTASSIUM; SPIRONOLACTONE;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MENSTRUAL IRREGULARITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SPOTTING; TREATMENT OUTCOME; WEIGHT GAIN;

ACNE VULGARIS; ADULT; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; ETHINYL ESTRADIOL; FEMALE; HUMANS; PROSPECTIVE STUDIES; RECEPTORS, ANDROGEN; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 37349031137     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.09.024     Document Type: Article

References (17)

1. Shaw J.C. Acne: effect of hormones on pathogenesis and management. Am J Clin Dermatol 3 (2002) 571-578
2. Lucky A.W., Henderson T.A., Olson W.H., Robisch D.M., Lebwohl M., and Swinyer L.J. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 37 (1997) 746-754
3. Redmond G.P., Olson W.H., Lippman J.S., Kafrissen M.E., Jones T.M., and Jorizzo J.L. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 89 (1997) 615-622
4. van Vloten W.A., van Haselen C.W., van Zuuren E.J., Gerlinger C., and Heithecker R. The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis 69 Suppl 4 (2002) 2-15
5. Gollnick H., Albring M., and Brill K. The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type. Ann Endocrinol (Paris) 60 (1999) 157-166
6. Jemec G.B.E., Linneberg A., Nielsen N.H., Frølund L., Madsen F., and Jørgensen T. Have oral contraceptives reduced the prevalence of acne? A population-based study of acne vulgaris, tobacco smoking and oral contraceptives. Dermatology 204 (2002) 179-184
7. Rabe T., Kowald A., Ortmann J., and Rehberger-Schneider S. Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro. Gynecol Endocrinol 14 (2000) 223-230
8. Thorneycroft I.H., Gollnick H., and Schellschmidt I. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment. Cutis 74 (2004) 123-130
9. Rübig A. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties. Climacteric 6 Suppl 3 (2003) 49-54
10. Goodfellow A., Alaghband-Zadeh J., Carter G., Cream J.J., Holland S., Scully J., et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol 111 (1984) 209-214
11. Burke B.M., and Cunliffe W.J. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. [letter]. Br J Dermatol 112 (1985) 124-125
12. Muhlemann M.F., Carter G.D., Cream J.J., and Wise P. Oral spironolactone: an effective treatment for acne vulgaris in women. Br J Dermatol 115 (1986) 227-232
13. Hatwal A., Bhatt R.P., Agrawal J.K., Singh G., and Bajpai H.S. Spironolactone and cimetidine in treatment of acne. Acta Derm Venereol (Stockh) 68 (1988) 84-87
14. Hughes B.R., and Cunliffe W.J. Tolerance of spironolactone. Br J Dermatol 118 (1988) 687-691
15. Shaw J.C. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol 43 (2000) 498-502
16. De Leo V., and Morgante G. Different effectiveness of cyproterone acetate doses in treatment of acne. Clin Endocrinol 58 (2003) 246-247
17. Krattenmacher R. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception 62 (2000) 29-38